Differential expression of CDC25 phosphatases splice variants in human breast cancer cells

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 10, 2011, Pages 1707-1714

  Albert, Hélène ^a   Santos, Susana ^b,c   Battaglia, Eric ^a   Brito, Miguel ^d   Monteiro, Carolino ^b,e   Bagrel, Denyse ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^d INSTITUTO POLITÉCNICO DE LISBOA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

alternative splicing; breast cancer; CDC25 phosphatases; prognostic markers

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; DOXORUBICIN; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 25A; PROTEIN TYROSINE PHOSPHATASE 25A1; PROTEIN TYROSINE PHOSPHATASE 25A2; PROTEIN TYROSINE PHOSPHATASE 25B; PROTEIN TYROSINE PHOSPHATASE 25B1; PROTEIN TYROSINE PHOSPHATASE 25B2; PROTEIN TYROSINE PHOSPHATASE 25B3; PROTEIN TYROSINE PHOSPHATASE 25B4; PROTEIN TYROSINE PHOSPHATASE 25C; PROTEIN TYROSINE PHOSPHATASE 25C1; PROTEIN TYROSINE PHOSPHATASE 25C2; PROTEIN TYROSINE PHOSPHATASE 25C3; PROTEIN TYROSINE PHOSPHATASE 25C4; PROTEIN TYROSINE PHOSPHATASE 25C5; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL LINE; CELL STRAIN MCF 7; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; CDC25 PHOSPHATASES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 80054965134     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.635     Document Type: Article

References (40)

1. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 2009;9:153-66.
2. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: Key players? Good targets? Nat Rev Cancer 2007;7:495-507. (Pubitemid 46985396)
3. Karlsson-Rosenthal C, Millar JB. Cdc25: Mechanisms of checkpoint inhibition and recovery. Trends Cell Biol 2006;16:285-92. (Pubitemid 43868088)
4. Aressy B, Ducommun B. Cell cycle control by the CDC25 phosphatases. Anticancer Agents Med Chem 2008;8:818-24.
5. Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H, et al. CDC25A is a novel phosphatase functioning early in the cell cycle. EMBO J 1994;13:1549-56. (Pubitemid 24114705)
6. Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge W, Hoffmann I. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 1998;111: 2445-53. (Pubitemid 28434930)
7. Millar JB, Blevitt J, Gerace L, Sadhu K, Featherstone C, Russell P. p55 cdc25 is a nuclear phosphorylation required for the initiation of mitosis in human cells. Proc Natl Acad Sci USA 1991;88:10500-4. (Pubitemid 21915863)
8. Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006;18:185-91. (Pubitemid 43375887)
9. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, et al. Cdc25 phosphatases as potential human oncogenes. Science 1995;269:1575-7.
10. Cangi MG, Cukor B, Soung P, Signoretti S, Moreira GJ, Ranashinge M, et al. Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 2000;106:753-61.
11. Ito Y, Yoshida H, Uruno T, Takamura Y, Miya A, Kuma K, et al. Expression of cdc25A and cdc25B phosphatase in breast carcinoma. Breast Cancer 2004;11:295-300.
12. Bonin S, Brunetti D, Benedetti E, Gorji N, Stanta G. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri-and postmenopausal breast cancer. Virchows Arch 2006;448:539-44. (Pubitemid 44490550)
13. Königsberg R, Rögelsperger O, Jäger W, Thalhammer T, Klimpfinger M, De Santis M, et al. Cell cycle dysregulation influences survival in high risk breast cancer patients. Cancer Invest 2008;26:734-40.
14. Mehdipour P, Pirouzpanah S, Sarafnejad A, Atri M, Shahrestani ST, Haidari M. Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients. Cell Biol Int 2009;33:1050-6.
15. Broggini M, Buraggi G, Brenna A, Riva L, Codegoni AM, Torri V, et al. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res 2000;20:4835-40. (Pubitemid 32127739)
16. Hernández S, Bessa X, Beà S, Hernández L, Nadal A, Mallofré C, et al. Differential expression of cdc25 cell-cycle activating phosphatases in human colorectal carcinoma. Lab Invest 2001; 81:465-73. (Pubitemid 32298791)
17. Nishioka K, Doki Y, Shiozaki H, Yamamota H, Tamura S, Yasuda T, et al. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus. Br J Cancer 2001;85:412-21. (Pubitemid 32747711)
18. Wu W, Fan YH, Kemp BL, Walsh G, Mao L. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc1. Cancer Res 1998;58:4082-5. (Pubitemid 28440560)
19. Hernández S, Hernández L, Beà S, Pinyol M, Nayach I, Bellosillo B, et al. Cdc25A and the splicing variant cdc25B2, but not cdc25B1,-B3 or-C, are over-expressed in aggressive human non-Hodgkin's lymphomas. Int J Cancer (Pred Oncol) 2000;89:148-52. (Pubitemid 30185923)
20. Kristjánsdóttir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol 2004;11:1043-51. (Pubitemid 39138756)
21. Ozen M, Ittmann M. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer. Clin Cancer Res 2005;11:4701-6. (Pubitemid 41557188)
22. Wang Z, Trope CG, Florenes VA, Suo Z, Nesland JM, Holm R. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes. BMC Cancer 2010;10:233.
23. Wegener S, Hampe W, Herrmann D, Schaller HC. Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C. Eur J Cell Biol 2000;79:810-5.
24. Baldin V, Cans C, Superti-Furga G, Ducommun B. Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene 1997;14:2485-95.
25. Forrest AR, McCormack AK, DeSouza CP, Sinnamon JM, Tonks ID, Hayward NK, et al. Multiple splicing variants of cdc25B regulate G2/M progression. Biochem Bioph Res Com 1999;260:510-5. (Pubitemid 29352093)
26. Bureik M, Rief N, Drescher R, Jungbluth A, Montenarh M, Wagner P. An additional transcript of the cdc25C gene from A431 cells encodes a functional protein. Int J Oncol 2000;17: 1251-8.
27. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, et al. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 2009;16:670-7.
28. Brinkman BM. Splice variants as cancer biomarkers. Clin Biochem 2004;37:584-94. (Pubitemid 38845021)
29. Soule HD, Vasquez J, Long A, Albert S, Brennan MA. Human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer I 1973;51:1409-16.
30. Whelan RD, Waring CJ, Wolf CR, Hayes JD, Hosking LK, Hill BT. Overexpression of p-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro. Int J Cancer 1992;52:241-6.
31. Cailleau R, Young R, Olivé M, Reeves WJ. Breast tumor cell lines from pleural effusions. J Natl Cancer I 1974;53:661-74.
32. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986;261:15544-9.
33. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8. (Pubitemid 351818697)
34. Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, et al. Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res 1997;57:2366-8. (Pubitemid 27255891)
35. Guo J, Kleeff J, Li J, Ding J, Hammer J, Zhao Y, et al. Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene 2004;23:71-81. (Pubitemid 38142241)
36. Tsuda H, Hashiguchi Y, Inoue T, Yamamoto K. Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium. Oncology 2003;65:159-66. (Pubitemid 37025978)
37. Caudill JS, Porcher JC, Steensma DP. Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes. Leukemia Lymphoma 2008;49: 989-93. (Pubitemid 351942755)
38. Chen MS, Ryan CE, Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 2003;23:7488-97. (Pubitemid 37271450)
39. Kieffer I, Lorenzo C, Dozier C, Schmitt E, Ducommun B. Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene 2007;26:7847-58. (Pubitemid 350261790)
40. Venables J, Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Koh C, et al. Identification of alternative splicing markers for breast cancer. Cancer Res 2008;68:9525-31.